ARGX
argenx NV
856.90$
-2.2%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +129.7% | -47.1% | +124.9% | -36.4% | +134.9% | -41.3% | +19.9% | +18.9% | +184.4% | -59.5% | +116.9% | – | |
| – | +1,493.4% | -92.5% | +0.0% | +36.8% | +1,025.6% | -87.8% | +37.1% | -1.2% | +210.6% | -64.4% | +130.8% | – | |
| – | -37.3% | +94.4% | +18.8% | +20.9% | +32.5% | +4.2% | +17.9% | +21.5% | +181.6% | -58.9% | +115.5% | – | |
| – | +106.9% | -43.3% | +98.6% | -47.2% | +26.0% | +4.0% | +6.0% | +8.5% | +24.6% | +0.0% | +9.7% | – | |
| – | +3.5% | +18.8% | +44.6% | -18.6% | -7.6% | +7.6% | +53.1% | -20.5% | +25.6% | -16.0% | +50.0% | – | |
| – | +112.8% | -43.4% | +0.0% | +10.8% | +12.5% | +1.1% | +11.4% | +22.7% | +159.3% | -55.1% | +86.9% | – | |
| – | – | – | – | – | +726.3% | +20.5% | +44.3% | +71.7% | +143.1% | -53.7% | +114.9% | – | |
| – | +20.3% | +84.2% | +11.7% | +18.2% | +4.1% | +61.2% | -0.8% | -11.8% | +0.7% | +0.0% | +100.2% | – | |
| – | – | – | – | – | +98.3% | +15.9% | +41.8% | +34.6% | +156.9% | -57.0% | +125.1% | – | |
| – | – | -146.6% | – | – | – | -0.3% | +26.3% | – | – | – | – | – | |
| – | – | – | – | – | +846.9% | -80.4% | +44.8% | +40.3% | +204.0% | -65.0% | +129.2% | – | |
| – | – | – | – | – | +42.7% | +60.7% | +41.5% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.